Dementia medicine, particularly in the context of Alzheimer's Disease, focuses on various approaches to manage and treat cognitive decline. Current treatments primarily aim to alleviate symptoms rather than cure the underlying causes. Medications like cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) are commonly prescribed to improve cognitive function by enhancing neurotransmitter activity in the brain. Another class of drugs, NMDA receptor antagonists like memantine, helps regulate glutamate activity, which is involved in learning and memory. Beyond pharmacological interventions, holistic approaches include cognitive stimulation therapy, physical exercise, and supportive care to enhance quality of life. Ongoing research aims to develop disease-modifying treatments that target the underlying pathology of Alzheimer's, addressing beta-amyloid plaques and tau tangles, to potentially slow disease progression.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China